|
KDELC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.3998995819835E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.7075999503291E-09 |
| Normal-vs-Stage2 |
4.684600E-03 |
| Normal-vs-Stage3 |
2.624700E-04 |
| Normal-vs-Stage4 |
1.027190E-01 |
| Stage1-vs-Stage2 |
5.196600E-01 |
| Stage1-vs-Stage3 |
7.993200E-01 |
| Stage1-vs-Stage4 |
4.717000E-01 |
| Stage2-vs-Stage3 |
7.100000E-01 |
| Stage2-vs-Stage4 |
8.303800E-01 |
| Stage3-vs-Stage4 |
6.081800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.52089485239549E-11 |
| Normal-vs-AfricanAmerican |
2.318400E-03 |
| Normal-vs-Asian |
3.300200E-01 |
| Caucasian-vs-AfricanAmerican |
7.909900E-02 |
| Caucasian-vs-Asian |
4.246400E-01 |
| AfricanAmerican-vs-Asian |
9.740200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.12614387101939E-12 |
| Normal-vs-Female |
5.490000E-02 |
| Male-vs-Female |
7.95970000000423E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.646000E-04 |
| Normal-vs-Extreme_Weight |
2.3504975743549E-11 |
| Normal-vs-Obese |
8.37100000000701E-05 |
| Normal-vs-Extreme_Obese |
1.075200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.362790E-01 |
| Normal_Weight-vs-Obese |
9.993800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.836800E-01 |
| Extreme_Weight-vs-Obese |
7.503600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.955200E-01 |
| Obese-vs-Extreme_Obese |
7.632600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.382900E-03 |
| Normal-vs-Age(41-60Yrs) |
2.10369999997795E-06 |
| Normal-vs-Age(61-80Yrs) |
6.14459594316941E-11 |
| Normal-vs-Age(81-100Yrs) |
2.231900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.574000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.408200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.834000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.337600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.987800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.711400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.31109575921096E-11 |
| Normal-VS-Type2 PRCC |
7.28460003429632E-09 |
| Normal-VS-KIRP CIMP |
6.809200E-01 |
| Normal-VS-Unclassified PRCC |
9.502300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.026600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.547380E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.125200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.862560E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.230600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.556000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.46069999995557E-06 |
| Normal-vs-N1 |
1.544970E-03 |
| Normal-vs-N2 |
7.161400E-01 |
| N0-vs-N1 |
7.810800E-01 |
| N0-vs-N2 |
1.597350E-01 |
| N1-vs-N2 |
2.242600E-01 |
|
|
